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Although transmissible spongiform encephalopathies (TSE) or prion diseases are neurodegenerative
disorders, the immune system is also involved, at least in the early stages of their pathogenesis.
Extensive studies have focused on cells targeted by the TSE agent for its replication but few on the
possible involvement of macrophages in its clearance, as in more conventional diseases. This review
summarises some of the experiments aimed at demonstrating a role for macrophages in TSE and
presents the application to TSE of the macrophage “suicide” technique, which has been used to clarify
the implication of these cells in the early steps of TSE pathogenesis.
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INTRODUCTION
Transmissible spongiform encephalopathies (TSE) or
prion diseases are a group of fatal neurodegenerative
disorders, including natural scrapie in sheep and goats,
bovine spongiform encephalopathy (BSE) in cattle and
Creutzfeldt–Jakob disease (CJD) in humans. CJD itself
can be classiﬁed in three sub-categories: sporadic,
inherited (associated with coding mutations in the prion
protein gene PRNP) or infectious (encompassing con-
tamination with CJD agent during medical interventions).
Variant CJD (vCJD) is the most recent recognised form of
infectious CJD and thought to originate from BSE (for
review see, Collinge, 1999). TSE are characterized by the
accumulation of a partially protease-resistant isoform
(PrPres) of the host encoded prion protein (PrP
c) in the
central nervous system (Prusiner, 1982). PrPres is mainly
associated with TSE agent infectivity; but whether or not
this abnormal protein constitutes its sole component
remains controversial (Caughey and Chesebro, 1997;
Lasmezas et al., 1997; Prusiner et al., 1998).
Most of our knowledge of TSE pathogenesis has been
established using experimental rodent models adapted
from natural disease (Kimberlin and Walker, 1988).
Studies after peripheral infection are particularly impor-
tant, as it represents the major route of contamination for
many natural TSE such as BSE, iatrogenic CJD related to
human growth hormone contamination and probably
vCJD. After intraperitoneal infection, the lymphoreticular
system (LRS) constitutes the ﬁrst target for TSE agent
replication: in murine models of scrapie and BSE,
infectivity (Kimberlin and Walker, 1988) and PrPres are
rapidly detected in the spleen and soon after, in Peyer’s
patches, lymph nodes, thymus and pancreas (Grathwohl
et al., 1996; Beringue et al., 1999a; Maignien et al., 1999).
After oral infection with murine BSE or scrapie, PrPres is
detectable ﬁrst in Peyer’s patches and then in lymph nodes
and in the spleen (Maignien et al., 1999). This peripheral
contamination is observed long before neuroinvasion
occurs (Kimberlin and Walker, 1988; Beringue et al.,
1999a; Maignien et al., 1999). Tissues of the immune
system are similarly infectious in natural scrapie (Hadlow
et al., 1982) and more strikingly accumulates PrPres in
vCJD (Hill et al., 1999), unlike other forms of CJD
(Kitamoto et al., 1989; Brown et al., 1994). The transport
of the TSE agent from the LRS to the central nervous
system most probably takes place via autonomic nerves
linking LRS organs to the thoracic spinal cord (Kimberlin
and Walker, 1988; 1989; Beekes et al., 1996) or via the
vagus nerve (Beekes et al., 1998).
The nature of immune cells involved in TSE agent
replication in the LRS is not clearly known. Replication
does not exclusively occur in T cells since both
thymectomized mice, nude mice and transgenic mice
lacking functional T cells are fully susceptible to
experimental scrapie infection, after peripheral inocu-
lation (Fraser and Dickinson, 1978; Mohri et al., 1987;
Klein et al., 1997). Moreover, PrP
c expression restricted
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in the LRS after intraperitoneal infection (Raeber et al.,
1999a). However, splenic T cells have been shown to
contain substantial amounts of scrapie infectivity
(Lavelle et al., 1972; Raeber et al., 1999b); but only
when they express PrP
c at their surface (Raeber et al.,
1999b). Whole body irradiation and splenocytes
fractionation have suggested that the cells supporting
scrapie agent replication are non-dividing stromal cells
(Clarke and Kimberlin, 1984; Fraser and Farquhar,
1987). Furthermore, PrPres accumulates in large
amounts in splenic follicular dendritic cells (FDC) of
scrapie-infected mice (McBride et al., 1992; Muramoto
et al., 1993). Hence, TSE agent replication may occur
speciﬁcally within FDC. The presence of mature B cells
is necessary for scrapie propagation, whether or not they
express PrP
c (Klein et al., 1997; 1998) and splenic B
lymphocytes are associated with scrapie infectivity only
when they express PrP
c (Raeber et al., 1999b). This can
be most readily explained by a requirement for B cells in
FDC maturation (Fu et al., 1998; Gonzalez et al., 1998).
Whatever the relative importance of individual cell
types, a partly or totally functional immune system is
required for scrapie propagation from the periphery to
the central nervous system after intraperitoneal infection,
as the disease is delayed in splenectomized mice (Fraser
and Dickinson, 1978) and did not or occur rarely in a
panel of immunodeﬁcient mice with deﬁcits in B/T, B
lymphocytes and FDC development, such as SCID mice,
Rag
0/0 or mMT mice (O’Rourke et al., 1994; Lasmezas
et al., 1996; Klein et al., 1997; 1998; Beringue et al.,
1999b).
The involvement of macrophages in the pathogenesis of
experimental TSE has also been studied: their phagocytic
capacity could theoretically interfere with TSE agent
replication and conversely they could also permit
replication since they are radioresistant, express PrP
c
and are distributed throughout LRS tissues. This review
synthesises experiments performed to deﬁne the role of
macrophages.
IN VITRO INTERACTION OF PERITONEAL
MACROPHAGES WITH THE SCRAPIE AGENT
Carp and Callahan (1981) showed that mouse scrapie
inoculum and mouse peritoneal macrophages associated
in vitro, suggesting an interaction between macrophages
and the scrapie agent, probably due to phagocytosis. They
then measured infectivity associated with a culture of
peritoneal macrophages, exposed during 2h with scrapie
inoculum (Carp and Callahan, 1982). Variations in
infectivity were assessed by measuring scrapie incubation
period in recipient mice infected with the macrophage
culture (Table I and Carp and Callahan, 1982). Incubation
of peritoneal macrophages during 4–5 days after exposure
to scrapie homogenate increased recipient mice incubation
period, suggesting that they have destroyed some
infectivity, compared to mice inoculated with the 2h
incubation mixture or with the scrapie strain used (ME7)
incubated without the cells (Table I). Peritoneal
macrophages were also washed after the 2h exposure
with scrapie homogenate before extended incubation, to
remove the amount of scrapie agent not associated with
these cells. In this case, the incubation period of recipient
mice inoculated with scrapie-exposed macrophages is also
prolonged, even after 28 days culture (Table I). It was
noteworthy that the medium removed from the macro-
phage culture was not infectious and that destroying
macrophages by UV irradiation after the 2h exposure to
scrapie produced more infectivity (Carp and Callahan,
1982). Therefore, the decrease in infectivity observed is
likely due to macrophages activity itself.
This has also been demonstrated using the PC12, a rat
phaeochromocytoma cell line, which can be differentiated
into neuronal-like cells, after nerve growth factor
treatment (Greene and Tischler, 1976). These cells permit
the replication of the 139A scrapie strain in vitro, without
any cytopathological changes (Rubenstein et al., 1984).
Exposure of scrapie-infected PC12 cells to mouse
peritoneal macrophages reduced the amount of infectivity
associated to the culture (Rubenstein et al., 1984),
TABLE I Reduction in scrapie infectivity after in vitro mouse peritoneal macrophages incubation with mouse scrapie strain ME7 (from Carp and
Callahan, 1982)
Recipient mice* inoculation with:
Scrapie incubation period (days ^ s.e.m.) after in vitro culture for:
2h 4–5 days 14 days 28 days
Without wash
ME7
† 161 ^ 2 169 ^ 2
ME7 þ macrophages
† 163 ^ 2 177 ^ 2
‡
With wash
ME7 165 ^ 1 168 ^ 1
ME7 þ macrophages 170 ^ 3 183 ^ 3
‡ 263 ^ 15
‡
ME7 þ macrophages 203 ^ 7 332 ^ 48
‡
Macrophages were exposed to 1% scrapie brain homogenate for 2h at 378C. They were then either washed or not, before extended culture until 28 days. Scrapie infectivity
associated to the culture was assessed by measuring incubation period in recipient mice infected with the latter.
*Five to six mice were inoculated. In each experiment, all developed scrapie.
†Mean of ﬁve differents experiments.
‡Statistically signiﬁcant ðp , 0:01Þ:
V. BERINGUE et al. 20suggesting again that macrophages can interfere with
scrapie agent replication.
These in vitro studies suggest, therefore, that macro-
phages may be able to inactivate TSE agent, probably due
to their phagocytic abilities. Experiments related to
infectivity and PrPres distribution in the spleen support the
idea that they could be similarly be efﬁcient in vivo.
ASSOCIATION OF INFECTIVITYAND PRPRES
WITH SPLEEN MACROPHAGES
Cell Fractionation of Splenocytes from
Scrapie-infected Rodents
Spleen fractionation experiments in experimental mouse
and hamster scrapie have been performed to measure
the amounts ofinfectivity associated with macrophages. In
C57BL/6 mice infected with the 139A scrapie strain (Carp
et al., 1994), infectivity was always found in higher quan-
tities in adherent spleen cells compared to non-adherent
spleen cells, during the course of the disease, either after
intracerebral or intraperitoneal inoculation (Table II).
These results were identical to those observed in hamsters
intraperitoneally infected with the 263K scrapie strain
(Robinson and Gorham, 1990) and support the idea that
splenic macrophages could carry some infectivity.
However, with a different mouse strain (Compton strain),
the results were opposite (Lavelle et al., 1972), suggesting
that the association of macrophages with infectivity may
depend on the experimental model used.
Immunodetection of PrPres and Vacuolization
Associated to Spleen Macrophages
In sheep at the terminal stages of natural scrapie, granules
of PrPres have been immunodetected in macrophages
associated with lymphoid follicles (Van Keulen et al.,
1996). In experimental mouse scrapie, ﬁbrils of PrPres
were detected by immunogold electron microscopy in
lysosomes of tangible body macrophages from the splenic
white pulp (Jeffrey et al., 2000). Finally, during the
adaptationofahamsterCJDstrain(SYstrain)toratswhich
produced inﬂammatory host reactions, spleen macro-
phages showed vacuolation early after the infection,
suggesting that they could be involved in incorporating
and destroying the infectious agent (Manuelidis et al.,
1997).
These experiments suggest therefore that, in vivo,
macrophages could retain some infectivity/PrPres associa-
ted to TSE and can be involved in eliminating TSE agent.
PHARMACOLOGICAL MODIFICATION
OF MACROPHAGES STATUS IN
EXPERIMENTAL TSE
In order to specify the role of macrophages in TSE, drugs
known to modify macrophage functions in vivo have been
tested. This has been performed in various models of
experimental TSE. In earlier work, we found that
association of inﬂammatory reactions with macrophage
recruitment, induced by polyacrylamide, did not modify
the incubation period of mice infected with the C506M3
scrapie strain either by intracerebral or intraperitoneal
route (Dormont et al., 1989). Inductions had been
performed before or after the scrapie infection. Also silica,
which is known to block phagocytosis repeatedly failed to
modify mouse scrapie infection (Kimberlin and Walker,
1990). Finally, macrophage activation induced by thiogly-
colate reduced scrapie infectivity (Carp and Callahan,
1985) or not (Kimberlin and Walker, 1990), among the
experiments performed. Long term oral treatment with the
phenylsulfone dapsone has been shown to signiﬁcantly
prolong the survival time of CJD (SY strain) infected rats
(Manuelidis et al., 1998). It is likely that dapsone acts by
TABLE II Ratio ofscrapie infectivity foundin adherentand non-adherent splenocytes ofmiceinfectedintracerebrally (ic)or intraperitoneally (ip)with




Days of post-inoculation Route of infection a n-a Infectivity ratio of adherent to non-adherent cells
21 ic 6.3 £ 10
4 1.7 £ 10
4 3.7
ip 2.0 £ 10
5 2.1 £ 10
4 9.5
49 ic 4.6 £ 10
4 2.3 £ 10
4 2.0
ip 3.1 £ 10
5 2.2 £ 10
4 14
70 ic 2.0 £ 10
5 1.2 £ 10
5 1.7
ip 3.2 £ 10
5 5.3 £ 10
4 6.0
102 ic 3.1 £ 10
5 1.4 £ 10
4 22
ip 5.0 £ 10
6 6.5 £ 10
3 769
118 ic 6.9 £ 10
4 9.4 £ 10
3 7.3
ip 5.0 £ 10
4 2.7 £ 10
4 1.8
154 ic nd nd nd
ip 4.3 £ 10
5 5.1 £ 10
3 84
Three spleens were used per analysis point. Splenocytes were fractionated into adherent (a) and non-adherent (n-a) fraction, using tissue culture dishes with grids on their
culturing surfaces. Scrapie infectivity associated to the cells was measured in recipient mice by end point titration.
nd, not determined.
MACROPHAGES AND TSE 21activating macrophages in this inﬂammatory-like model
(Manuelidis et al., 1997; 1998), similarly to its effects on
HIV-1 replication in monocyte-derived macrophages
(Duval et al., 1997; Clayette et al., 1999).
The absence of an effect on TSE with several drugs
known to interfere with macrophages status seems
contradictory with experiments suggesting an interaction
between these cells and infectivity or PrPres in vivo or
in vitro. It is noteworthy that the consequences of these
drug treatments were only studied by titrating infectivity
in the terminal stage of the disease and these results do not
exclude treatment effects at earlier stages of the infection,
prior and during early TSE agent neuroinvasion. More-
over, the fact that infectivity must vary more than 1 Log
LD50 to be statistically signiﬁcant renders consequently
small effects (which are observed for silica, Kimberlin and
Walker, 1990) of these drugs border-line.
APPLICATION OF THE MACROPHAGE
“SUICIDE” TECHNIQUE TO SCRAPIE-INFECTED
MICE
Principle of the Technique
The macrophage “suicide” technique consists of the
administration to rodents of liposome-encapsulated
dichloromethylene diphosphonate (Cl2MDP), also called
clodronate (Van Rooijen, 1989). As clodronate (Fig. 1) is
hydrophilic, it is entrapped during the formation of
multilamellar liposomes and targeted more speciﬁcally to
macrophages (Van Rooijen, 1989). Clodronate is then
released in these cells by phospholipase action on
liposomes. Although, the mechanism of action of
clodronate is unknown, the drug might inactive macro-
phage phagocytosis by chelating Ca
2þ or metallic ions
(Van Rooijen, 1991) or directly inducing apoptosis (Naito
et al., 1996). Macrophages from different tissues can be
speciﬁcally targeted depending on the route of adminis-
tration; intravenous injection of liposome-encapsulated
clodronate depletes mainly spleen macrophage subsets
and Kupffer cells of liver; subcutaneous injection depletes
draining lymph nodes (Van Rooijen and Sanders, 1994).
Generally, macrophages are depleted by a single
intravenous injection of 2mg liposome-entrapped
Cl2MDP in 200ml (Van Rooijen, 1989).
Depletion of Spleen Macrophages after Intravenous
Administration of Liposome-encapsulated Clodronate
The status of spleen macrophages can be assessed by
measuring acid-phosphatase activity on spleen cryostat
section (Fig. 2a). Within 1 day of administration,
the intravenous injection of liposome-encapsulated
clodronate strongly reduces this activity (Van Rooijen
and Sanders, 1994; Beringue et al., 1999c) and by 3 days,
elimination of all spleen macrophage subpopulations is
nearly complete (Fig. 2b). Macrophages reappear on day
10 (Fig. 2c) and all macrophage subsets have fully
repopulated the spleen around 1–2 months after
clodronate administration (Van Rooijen et al., 1989;
1990; Laman et al., 1990; Beringue et al., 1999c).
Administration of Liposome-encapsulated
Clodronate to Scrapie-infected Mice
As previous experiments had shown that macrophage
function modiﬁcations had no effects during the late
FIGURE 2 Depletion of spleen macrophages induced by liposome-
encapsulated clodronate administration. Macrophage depletion was
assessed on spleen sections by measuring acid-phosphatase activity
3 days (b) or 10 days (c) after intravenous liposome-encapsulated
clodronate injection to mice and by comparing it to untreated or empty-
liposomes treated mice (a). ( £ 40).
FIGURE 1 Chemical structure of dichloromethylene diphosphonate or
clodronate.
V. BERINGUE et al. 22phases of the disease (see above), we use the macrophage
“suicide” technique to study the role of macrophages
during early scrapie pathogenesis in the spleen. PrPres
accumulation was used as the most sensitive and speciﬁc
molecular hallmark of mouse scrapie agent as it has been
shown to vary signiﬁcantly even when variation in
infectivity was not signiﬁcant, such as for the effects of
the polyene antibiotic amphotericin B (Adjou et al.,
1999).
In C57BL/6 mice infected intraperitoneally with the
C506M3 scrapie strain, the kinetics of PrPres
accumulation in the spleen shows four distinct phases
(Beringue et al., 1999a); (i) the almost immediate
detection of PrPres associated with the scrapie
inoculum, (ii) a phase where the scrapie inoculum has
been dispersed/cleared, where PrPres cannot be
detected, from 1 to 4 days post-inoculation (dpi),
(iii) the onset of the replication phase from 5 dpi, as
newly synthesized PrPres accumulates in the spleen,
(iv) a plateau of spleen PrPres accumulation 1–2
months after scrapie infection until the terminal
stage of the disease (Fig. 3). The consequences of
liposome-encapsulated Cl2MDP administration were
studied on these different phases, to examine a possible
scavenger role of macrophages in the early steps of
scrapie pathogenesis in the spleen.
Scrapie Inoculum Clearance by Macrophages
The ﬁrst clodronate treatment ensured splenic macro-
phages depletion at the day of scrapie infection (Fig. 4a).
The consequences of it were that (i) more PrPres
associated with the scrapie inoculum was detectable in
the spleen the day of infection and (ii) there was an
increase in newly synthesized PrPres during 20 days post-
inoculation (Fig.4a). Thus, macrophage depletion induced
prior to scrapie inoculation increased the amount of
detectable inoculum in the spleen the day of infection.
This excess of inoculum consequently induced a transient
increased in newly synthesized PrPres, during the early
steps of the pathogenesis. This study illustrates the
involvement of splenic macrophages in the clearance of
scrapie inoculum at the day of infection, most probably
resulting from their ability to phagocytose insoluble
PrPres.
Involvement of Macrophages in PrPres Catabolism
We next assessed the outcome for PrPres synthesis of
macrophage depletion at the end of inoculum clearance
phase (Fig. 4b). This regimen also led to a signiﬁcant
increase of spleen PrPres accumulation (Fig. 4b). This
suggests that, in untreated mice, macrophages have
FIGURE 3 Distinct phases in PrPres accumulation in the spleen of scrapie-infected mice (from Beringue et al., 1999a). C57BL/6 mice were infected
with 100–200ml of a 1–2% brain homogenate of terminally ill animals, by the intraperitoneal route. PrPres was quantiﬁed from the day of inoculation
(day 0) until the terminal stage of the disease (260–280 days post-inoculation).
MACROPHAGES AND TSE 23FIGURE 4 PrPres accumulation in the spleen of scrapie-infected mice, following clodronate-containing liposomes administration. Liposome-
encapsulated clodronate was injected either 2 days before (a) or 1 day after (b) scrapie inoculation (plain line). Representative spleen PrPres detection is
presented at 10 (a) and 20 (b) days post-inoculation (dpi). Empty liposomes-treated mice have been used as controls (dotted line).
V. BERINGUE et al. 24the capacity to eliminate newly synthesized PrPres
molecules, produced in small amounts just after the
post-clearance phase in the spleen (Beringue et al.,
1999c).
Cells Involved in Scrapie Agent Replication after
Clodronate Administration?
We also studied whether other cells in the spleen were
depleted by intravenous clodronate administration,
particularly those reported to be involved in TSE
pathogenesis. This was necessary to ensure that the
effects we observed with clodronate were speciﬁc to
macrophage depletion. Using standard immunohisto-
chemistry, T lymphocytes were unaffected by the
treatment (Fig. 5a and d), as previously described
(Laman et al., 1990; Nair et al., 1995). In contrast, B
lymphocytes were strongly depleted during the 6–16 day
period after Cl2MDP-containing liposomes administration
(Fig. 5b and e) but repopulated very rapidly (Beringue
et al., 1999c). FDC numbers were also reduced between
the 3–16 day period, the strongest effect seen at day 10
(Fig. 5c and f); thereafter the number of FDC slowly
increased (Beringue et al., 1999c). These alterations were
speciﬁc for clodronate administration, as the injection of
liposomes alone did not modify immunohistochemical
staining of the cell populations studied (Fig. 5a and c).
Possibly, FDC and B cells have been reported to be
involved in scrapie agent replication in the spleen (Clarke
and Kimberlin, 1984; Fraser and Farquhar, 1987; McBride
et al., 1992; Muramoto et al., 1993; Klein et al., 1997;
1998). The depletion of these cells after clodronate
administration, when detectable PrPres is increased in the
spleen suggests the existence of compensatory mechan-
isms at the cellular or tissue level allowing the scrapie
agent to persist and even replicate in the absence of B cells
and FDC. As T cells were not affected by clodronate
administration, it is tempting to suggest that they have a
potential to be target cells. This would occur only in
situations where the preferential targets, such as FDC, are
not available, as a preponderant role has never been
described for T lymphocytes (Fraser and Dickinson, 1978;
Mohri et al., 1987; Klein et al., 1997; Raeber et al.,
1999a). It is noteworthy that in situations of T and B
lymphocytes and FDC impairment, such as in SCID mice,
no synthesis of PrPres was detectable in the spleen early in
the infection (Beringue et al., 1999a).
The Plateau of Spleen PrPres Accumulation may
Correspond to a lack of PrPres Synthesis
A last clodronate treatment was performed when PrPres
accumulation, as infectivity (Kimberlin and Walker, 1979)
had reached a plateau. The plateau phase has been
proposed as the consequence of the restriction of the
scrapie agent replication, due to the limited number of
non-dividing target cells (Kimberlin and Walker, 1988).
But whether the plateau results from a cessation of agent
replication when all target cells are saturated, or from a
dynamic equilibrium between synthesis and degradation
remains to be determined (Kimberlin and Walker, 1988).
A transient disappearance of FDC, B cells and
macrophages, induced by clodronate treatment during
the plateau phase did not modify PrPres accumulation
(Beringue et al., 1999c) unlike the earlier treatments
(Fig. 4), supporting the idea of a lack of PrPres synthesis
and therefore, a cessation of replication activity in the
target cells at this time. The absence of effects obtained
with clodronate during the plateau is similar to that
observed with polyanions, although these drugs have
FIGURE5 Follicular dendriticcells, B lymphocytes but not T lymphocytes are transientlyaffected by clodronate treatment.Spleen cryostatsectionso f
untreated or empty liposomes-treated (a–c) and clodronate-treated mice (d–f) were prepared. T lymphocytes, B lymphocytes and follicular dendritic
cells were immunohistochemically stained with anti-Thy1.2 (a and d), anti-B220 (b and e) and anti-CD35, clone 8C12 (c and f), respectively. Analyses
were performed 10 days after liposome-encapsulated clodronate administration. ( £ 40).
MACROPHAGES AND TSE 25profond effects on the immune system. They could not
delay experimental scrapie when administered remote
from the time of inoculation, despite being efﬁcient when




and transport are not clearly known, all these data suggest
thatmacrophagescaninteractandinterferewithTSEagent
propagation. These effects are probablymore prominent in
the very early stage of infection in the periphery as late
treatment with clodronate did not modify the course of
PrPres accumulation in the spleen, and, as the amount of
infectivity carried by macrophages did not vary greatly
during the time course of scrapie (Table II and Carp et al.,
1994). This role of macrophages as the ﬁrst natural host
defender at the time of TSE infection is similar to that
observedinconventionaldiseases(Seileretal.,1997).The
involvement of macrophages also suggests that they could
passively contribute to TSE agent propagation, if they are
not able to destroy them, due to the strong resistance of
PrPres to proteolysis (Prusiner, 1982). Finally, clodronate
treatment has indicated the complexity of the involvement
and exact role of immunocompetent cells in scrapie
pathogenesis. FDC and lymphoid cells might act
cooperatively and one population could be able to take
the relay of the other one in case of cellular homeostasis
modiﬁcation. This may be an important complicating
factorintheongoingsearchforthecellulartargetsofTSEs.
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